A recent study also found enhanced serum and cerebrospinal fluid ATG5 and Parkin (a cytosolic E3 ubiquitin ligase mutated in Parkinson’s disease that promotes mitochondrial autophagy) levels in MS patients compared to patients with other inflammatory or non-inflammatory neurological diseases (18). This evidence concerns the gene ATG5 and myeloid sarcoma.